selected publications
-
Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Cancer discovery.
2018
Academic Article
GET IT
Times cited: 382 -
Malignant Pleural Mesothelioma: Are There Imaging Characteristics Associated With Different Histologic Subtypes on Computed Tomography?.
Journal of computer assisted tomography.
2018
Academic Article
GET IT
Times cited: 4 -
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2017
Academic Article
GET IT
Times cited: 44 -
Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1.
Oncotarget.
2017
Academic Article
GET IT
Times cited: 30 -
Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.
Immunotherapy.
2017
Information Resource
GET IT
Times cited: 40 -
Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis.
Molecular cancer therapeutics.
2017
Academic Article
GET IT
Times cited: 31 -
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study.
International journal of cancer.
2017
Academic Article
GET IT
Times cited: 31 -
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2016
Academic Article
GET IT
Times cited: 137 -
Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?.
The Lancet. Oncology.
2016
Article
GET IT
Times cited: 18 -
Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 106 -
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
PloS one.
2016
Academic Article
GET IT
Times cited: 15 -
A new standard for malignant pleural mesothelioma.
Lancet (London, England).
2015
Article
GET IT
Times cited: 10 -
Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2015
Academic Article
GET IT
Times cited: 53 -
A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2014
Academic Article
GET IT
Times cited: 32 -
Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase.
Lung cancer (Amsterdam, Netherlands).
2014
Academic Article
GET IT
Times cited: 48 -
Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands).
2014
Academic Article
GET IT
Times cited: 89 -
Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2013
Academic Article
GET IT
Times cited: 70 -
Toxicity of initial chemotherapy in older patients with lung cancers.
Journal of geriatric oncology.
2013
Academic Article
GET IT
Times cited: 18 - Important recent insights into the genetics and biology of malignant pleural mesothelioma. Annals of cardiothoracic surgery. 2012 Academic Article GET IT
- Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery. Annals of cardiothoracic surgery. 2012 Academic Article GET IT
-
New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2012
Academic Article
GET IT
Times cited: 71 -
Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.
International journal of radiation oncology, biology, physics.
2012
Academic Article
GET IT
Times cited: 123 - Novel therapies in phase II and III trials for malignant pleural mesothelioma. Journal of the National Comprehensive Cancer Network : JNCCN. 2012 Information Resource GET IT
-
The evolution of multimodality therapy for malignant pleural mesothelioma.
Current treatment options in oncology.
2011
Academic Article
GET IT
Times cited: 35 -
Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2010
Article
GET IT
Times cited: 5 -
Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer.
Breast cancer research and treatment.
2008
Academic Article
GET IT
Times cited: 45 -
Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
Breast cancer research and treatment.
2005
Academic Article
GET IT
Times cited: 43